secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2024-09-30T23:59:59+00:00
Accession:  0001193125-24-228399
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vor Bio appoints Han Choi as CFO, effective Sept 30, 2024
---------------------------------------------------------

- Han Choi, M.D., LL.M., named CFO; previously Principal at Oracle Investment Management for over 20 years.
- Base salary of $464,000 per year and target annual bonus of 40% of base salary.
- Granted stock option for 400,000 shares, vesting over 4 years (1/4 after 1 year, then monthly).
- Choi brings experience in healthcare investment, business development, and capital markets strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312524228399/0001193125-24-228399-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312524228399/d829992d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-228399

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer